DNAJC5B, also known as CSP-beta (Cysteine String Protein beta), is a cytosolic protein involved in cellular stress responses and protein homeostasis. It interacts with HSC70 (a heat shock protein) to regulate protein folding and degradation. Unlike its paralog DNAJC5 (CSP-alpha), DNAJC5B exhibits tissue-specific expression patterns, particularly in the brain and pancreas .
The antibody is validated for:
Western blotting (WB): Detects DNAJC5B in lysates of neuronal and pancreatic cell lines.
Immunocytochemistry (ICC): Localizes DNAJC5B to cytoplasmic and perinuclear regions in cultured cells .
Immunoprecipitation (IP): Isolates DNAJC5B complexes for downstream mass spectrometry analysis .
| Application | Recommended Antibody Clones | Source |
|---|---|---|
| WB/ICC/IP | 17364-1-AP (Invitrogen) | |
| ELISA | FNab02467 (FineTest) |
Tauopathies: DNAJC5B facilitates the unconventional secretion of tau protein, a hallmark of Alzheimer’s disease. Overexpression of DNAJC5B enhances tau release via the MAPS (Misfolded Protein Secretion) pathway .
Synucleinopathies: Studies suggest DNAJC5B may also regulate α-synuclein secretion, implicating it in Parkinson’s disease pathology .
DNAJC5B forms complexes with HSC70 and substrate proteins (e.g., tau, α-synuclein) to mediate their extracellular release. This process involves Rab9-positive endosomes and is independent of the ubiquitin-proteasome system .
DNAJC5B encodes cysteine string protein (CSP) beta, which belongs to the DnaJ-like chaperone family. It plays an important role in regulated exocytosis in neurons and endocrine cells . The protein functions as a co-chaperone for the SNARE protein SNAP-25 and is involved in calcium-mediated control of late-stage exocytosis . DNAJC5B likely has an important role in presynaptic function and may be involved in calcium-dependent neurotransmitter release at nerve endings . Unlike its related protein CSPα (DNAJC5), which is ubiquitously expressed, DNAJC5B expression is restricted primarily to testis and auditory hair cell neurons, suggesting specialized functions in these tissues .
Several types of DNAJC5B antibodies are available for research applications, including:
Rabbit recombinant monoclonal antibodies (e.g., EPR24152-62) suitable for immunoprecipitation (IP), flow cytometry, Western blotting (WB), immunohistochemistry on frozen and paraffin sections (IHC-Fr, IHC-P)
Rabbit polyclonal antibodies suitable for Western blotting, immunofluorescence/immunocytochemistry (IF/ICC), and immunoprecipitation
Application validation data is typically available for these antibodies, with recommended dilutions as follows:
| Application | Typical Dilution Range |
|---|---|
| Western Blot (WB) | 1:500-1:3000 |
| Immunoprecipitation (IP) | 0.5-4.0 μg for 1.0-3.0 mg of total protein lysate |
| Immunofluorescence (IF)/ICC | 1:10-1:100 |
Most DNAJC5B antibodies have been tested and show reactivity with human, mouse, and rat samples .
DNAJC5B is one of three CSP proteins (α, β, γ) in mammals that belong to the DNAJ-like chaperone family . The key differences between DNAJC5B and DNAJC5 (CSPα) include:
Expression pattern: DNAJC5 (CSPα) is ubiquitously expressed, while DNAJC5B (CSPβ) expression is restricted primarily to testis and auditory hair cell neurons
Molecular weight: DNAJC5B has a predicted molecular weight of approximately 22 kDa
Functional specialization: While both proteins are involved in regulated exocytosis, DNAJC5 has been implicated in unconventional secretion pathways, including the secretion of α-synuclein, which is relevant to Parkinson's disease research
Both proteins undergo post-translational modifications, with palmitoylation being particularly important for the function of DNAJC5 .
For optimal detection of DNAJC5B across different experimental approaches, consider the following sample preparation methods:
Western Blotting:
Fresh tissue samples should be homogenized in RIPA buffer containing protease inhibitors
For mouse models, testis tissue yields the strongest signal due to high DNAJC5B expression
Protein denaturation should be performed at 95°C for 5 minutes in sample buffer containing SDS and DTT
Loading 20-50 μg of total protein per lane is typically sufficient for detection
Immunohistochemistry/Immunofluorescence:
For IHC-P: Fixation with 10% paraformaldehyde for 10 minutes has been validated
For frozen sections: Use fresh-frozen tissues sectioned at 5-8 μm thickness
Antigen retrieval may be necessary for some tissues, particularly for formalin-fixed samples
Blocking with 5% normal serum from the same species as the secondary antibody for 1 hour reduces background
Immunoprecipitation:
Use 0.5-4.0 μg of antibody for 1.0-3.0 mg of total protein lysate
Pre-clear lysates with protein A/G beads before adding the antibody to reduce non-specific binding
Overnight incubation at 4°C with gentle rotation typically yields optimal results
When troubleshooting weak or non-specific signals with DNAJC5B antibodies, consider these methodological approaches:
For weak signals:
Increase antibody concentration incrementally within the recommended range
Extend primary antibody incubation time (e.g., overnight at 4°C)
Optimize antigen retrieval methods for IHC/IF applications
Use more sensitive detection systems (e.g., enhanced chemiluminescence substrates for WB)
Enrich for DNAJC5B by using tissue with known high expression (testis, auditory hair cells)
Consider using fresh rather than frozen samples, as protein degradation may affect detection
For non-specific signals:
Titrate antibody concentration to determine optimal signal-to-noise ratio
Increase blocking time and concentration (5-10% blocking reagent)
Add additional washing steps with increased detergent concentration
Include competitive peptide controls to confirm specificity
Validate specificity using DNAJC5B knockout or knockdown samples as negative controls
Consider using monoclonal rather than polyclonal antibodies to reduce cross-reactivity
Pre-absorb antibodies with proteins from non-target species if cross-species reactivity is observed
To investigate DNAJC5B's role in regulated exocytosis, researchers should consider the following methodological approaches:
Co-immunoprecipitation studies: To examine interactions between DNAJC5B and SNARE proteins or other exocytosis-related proteins using validated antibodies for IP
Calcium imaging: To assess the impact of DNAJC5B knockdown or overexpression on calcium-mediated exocytosis in relevant cell types (particularly neurons or endocrine cells)
Live-cell imaging: Using fluorescently tagged DNAJC5B constructs to monitor localization during exocytosis events
Electrophysiology: Patch-clamp recordings to measure neurotransmitter release in cells with modified DNAJC5B expression
SNARE complex assembly assays: To determine how DNAJC5B affects the formation and stability of SNARE complexes involved in vesicle fusion
Vesicle release assays: Using fluorescent markers to quantify regulated release in response to stimulation in the presence or absence of DNAJC5B
Proximity ligation assays: To detect and quantify interactions between DNAJC5B and candidate partner proteins in situ
Super-resolution microscopy: To visualize DNAJC5B localization at synapses or secretory vesicles with nanometer precision
For studying specialized cell types where DNAJC5B is enriched, such as auditory hair cells, consider isolated cell preparations or organotypic cultures combined with the above techniques.
DNAJC5B shows enriched expression in auditory hair cells, suggesting specialized functions in these cells . To investigate these functions using DNAJC5B antibodies, researchers can employ the following approaches:
Cochlear immunohistochemistry mapping: Use validated antibodies for IHC-Fr or IHC-P to map the precise localization of DNAJC5B within different types of hair cells (inner vs. outer) and along the cochlear tonotopic axis
Co-localization studies: Combine DNAJC5B antibodies with markers for synaptic ribbons, afferent terminals, and efferent terminals to determine the precise subcellular localization of DNAJC5B in relation to known functional domains
Developmental expression analysis: Track DNAJC5B expression during cochlear development to identify critical periods where the protein may play important roles in synapse formation or maturation
Immunogold electron microscopy: Achieve ultrastructural localization of DNAJC5B in relation to synaptic vesicles and active zones in hair cells
Functional studies in cochlear explants: Combine antibody labeling with calcium imaging or patch-clamp recordings to correlate DNAJC5B expression with functional properties of hair cells
Hearing loss models: Assess changes in DNAJC5B expression or localization in genetic or noise-induced hearing loss models to identify potential roles in pathology
Selective synaptic isolation: Use antibodies to isolate and characterize DNAJC5B-containing protein complexes from purified ribbon synapses to identify hair cell-specific interaction partners
Given the similarity between DNAJC5B and DNAJC5 (CSPα), researchers need specialized approaches to distinguish their functions:
Parallel knockdown/knockout studies: Compare the phenotypic effects of selectively reducing either DNAJC5B or DNAJC5 expression in relevant cell types
Rescue experiments: In knockout backgrounds, express either DNAJC5B or DNAJC5 to determine which functions can be rescued by each protein
Domain swap experiments: Create chimeric proteins with domains from each protein to identify regions responsible for specific functions
Differential expression analysis: Leverage the distinct expression patterns (DNAJC5B in testis and auditory hair cells vs. ubiquitous DNAJC5 expression) to study functions in tissues where only one protein is naturally expressed
Selective antibody labeling: Use highly specific antibodies targeting non-conserved regions to visualize each protein separately in tissues expressing both
Interaction partner identification: Use immunoprecipitation with specific antibodies followed by mass spectrometry to identify unique binding partners for each protein
Conditional expression systems: Develop temporal and spatial control of expression to study acute vs. chronic effects of each protein independently
Single-cell transcriptomics: Identify cell populations that differentially express DNAJC5B vs. DNAJC5 to guide functional studies in the appropriate cellular context
Recent research has identified DNAJC5 as a mediator of unconventional secretion of α-synuclein, relevant to Parkinson's disease . To investigate whether DNAJC5B might have similar functions, researchers could:
Parallel secretion assays: Establish cell-based secretion assays similar to those used for DNAJC5-mediated α-synuclein secretion, expressing DNAJC5B instead of DNAJC5
Palmitoylation analysis: Since palmitoylation is essential for DNAJC5-mediated secretion , use metabolic labeling with palmitate analogs to determine if DNAJC5B undergoes similar modification
Oligomerization studies: Investigate whether DNAJC5B forms oligomers similar to those observed with DNAJC5, using approaches such as Blue Native PAGE or chemical crosslinking
Cargo identification: Use proximity labeling approaches (BioID, APEX) with DNAJC5B as bait to identify potential cargo proteins that might be secreted through a DNAJC5B-dependent pathway
Endosomal localization studies: Determine if DNAJC5B can facilitate translocation of cytosolic proteins to endosomal compartments, as observed with DNAJC5
Structure-function analysis: Generate mutations in DNAJC5B corresponding to those that affect DNAJC5 function (particularly palmitoylation sites) and assess their impact on potential unconventional secretion
Inhibitor studies: Test whether inhibitors of DNAJC5-mediated secretion similarly affect any DNAJC5B-dependent processes
When interpreting differences in DNAJC5B antibody reactivity across species and tissues, researchers should consider these analytical approaches:
Sequence conservation analysis: Compare DNAJC5B protein sequences across species to identify conserved and divergent epitopes that might affect antibody binding
Multiple antibody validation: Use antibodies targeting different epitopes of DNAJC5B to distinguish true expression differences from technical limitations
Transcript-protein correlation: Compare antibody reactivity with mRNA expression data (e.g., from RNA-seq or qPCR) to validate tissue-specific expression patterns
Control for post-translational modifications: Consider that tissue-specific modifications might mask epitopes in certain contexts
Species-specific optimization: Develop separate protocols optimized for each species rather than assuming conditions can be directly transferred
Quantitative analysis: Use standardized protein loading and quantitative Western blotting to accurately compare expression levels across tissues
Alternative splicing awareness: Consider that tissue-specific splicing variants might affect epitope availability
A systematic validation approach using these strategies will help distinguish biological differences from technical artifacts when interpreting cross-species and cross-tissue reactivity patterns.
For accurate quantitative analysis of DNAJC5B expression in comparative studies, researchers should address these methodological considerations:
Sample normalization strategy:
For Western blotting: Use multiple loading controls (e.g., GAPDH, β-actin, total protein stains) to normalize for protein content
For IF/IHC: Include reference markers with known expression levels
Signal detection linearity:
Perform standard curve analyses to confirm the linear range of detection for your antibody
Use appropriate exposure times for chemiluminescent detection or gain settings for fluorescence to prevent signal saturation
Biological and technical replication:
Include sufficient biological replicates (n≥3) to account for natural variation
Perform technical replicates to validate measurement reproducibility
Statistical approach:
Apply appropriate statistical tests based on data distribution
Control for multiple comparisons when analyzing multiple tissues or conditions
Controls for antibody specificity:
Include positive controls (tissues with known high expression)
Use negative controls (knockout/knockdown samples or competitive peptide blocking)
Integrated multi-method analysis:
Combine protein detection (Western blot, IHC) with mRNA quantification (qPCR, RNA-seq)
Consider absolute quantification approaches (using recombinant protein standards) for more precise comparisons
Reporting standards:
Document all experimental conditions, antibody details, image acquisition parameters, and analysis methods
Present raw data alongside normalized results for transparency
When faced with contradicting results from different DNAJC5B antibodies or detection methods, researchers should consider these analytical approaches:
Epitope mapping analysis:
Identify the exact epitopes recognized by each antibody
Consider whether post-translational modifications, protein folding, or sample preparation might differentially affect epitope accessibility
Method-specific artifacts assessment:
For Western blotting: Consider denaturation conditions, transfer efficiency, and membrane type
For IHC/IF: Evaluate fixation artifacts, antigen retrieval methods, and autofluorescence
For IP: Assess buffer conditions that might affect protein-protein interactions
Orthogonal validation strategies:
Use genetic approaches (siRNA, CRISPR) to validate specificity
Perform mass spectrometry analysis of immunoprecipitated bands
Express tagged versions of DNAJC5B for detection with anti-tag antibodies
Biological context considerations:
Different isoforms or post-translationally modified forms may predominate in different tissues
Protein complexes may mask certain epitopes in tissue-specific manner
Quantitative comparison framework:
Develop a systematic scoring system to evaluate reliability of each antibody based on multiple validation criteria
Weight evidence based on validation quality rather than treating all results equally
Sequential epitope analysis:
When possible, probe the same samples sequentially with different antibodies to directly compare detection patterns
For auditory neuroscience research focused on DNAJC5B, researchers should consider these specialized approaches:
Hair cell-specific isolation techniques:
Use fluorescence-activated cell sorting (FACS) of reporter-labeled hair cells to obtain pure populations
Apply single-cell or bulk RNA sequencing to correlate DNAJC5B expression with functional subtypes
Organotypic cochlear cultures:
Maintain the three-dimensional architecture of the organ of Corti while allowing experimental manipulation
Combine with time-lapse imaging to study dynamic processes
Specialized immunohistochemistry protocols:
Optimize decalcification procedures to preserve both bone structure and protein epitopes
Use tyramide signal amplification for detecting low-abundance signals in cochlear sections
Functional correlates:
Combine immunolabeling with patch-clamp recordings or calcium imaging
Correlate DNAJC5B localization with measures of synaptic function in hair cells
Noise exposure and ototoxicity models:
Examine changes in DNAJC5B expression or localization following acoustic trauma or ototoxic drug exposure
Test protective effects of manipulating DNAJC5B expression
Age-related changes:
Analyze DNAJC5B expression throughout development and aging
Correlate with functional metrics of auditory processing
Synaptic-level analysis:
Use super-resolution microscopy to precisely localize DNAJC5B at ribbon synapses
Employ serial block-face scanning electron microscopy for ultrastructural analysis
Genetic models:
Develop hair cell-specific conditional knockout models
Use viral vector-mediated expression of modified DNAJC5B proteins
To investigate potential links between DNAJC5B dysfunction and neurological disorders, researchers should consider these approaches:
Genetic association studies:
Analyze DNAJC5B variants in patient cohorts with auditory processing disorders, hearing loss, or other neurological conditions
Perform targeted sequencing of DNAJC5B in cases with unexplained auditory phenotypes
Expression analysis in disease models:
Examine DNAJC5B expression in animal models of hearing loss and neurodegeneration
Compare expression in post-mortem tissues from patients versus controls
Functional impact assessment:
Introduce disease-associated variants using CRISPR genome editing
Test effects on exocytosis, calcium handling, and synaptic function
Electrophysiological characterization:
Record synaptic transmission in neuronal cultures with altered DNAJC5B expression
Analyze auditory brainstem responses in animal models with DNAJC5B mutations
Protein interaction network analysis:
Identify changes in DNAJC5B's interactome under disease conditions
Look for overlap with known pathways involved in neurological disorders
Chemical modulator screening:
Develop assays to identify compounds that can rescue dysfunction caused by DNAJC5B mutations
Test FDA-approved drugs for repositioning potential
Secretome analysis:
To investigate DNAJC5B's co-chaperone function with SNAP-25 and other SNARE proteins, researchers can employ these methodological approaches:
In vitro chaperone assays:
Use purified recombinant proteins to assess DNAJC5B's ability to prevent SNAP-25 aggregation
Measure refolding of denatured SNAP-25 in the presence of DNAJC5B and Hsp70 family chaperones
SNARE complex assembly assays:
Monitor the formation of SDS-resistant SNARE complexes in the presence or absence of DNAJC5B
Use FRET-based approaches to measure SNARE complex assembly kinetics
Site-directed mutagenesis:
Introduce mutations in the J-domain of DNAJC5B to disrupt its interaction with Hsp70 chaperones
Create mutations in potential SNAP-25 binding regions to identify critical interaction sites
Advanced microscopy techniques:
Use FRET or FLIM to detect direct interactions between DNAJC5B and SNAP-25 in living cells
Apply single-molecule tracking to analyze the dynamics of these interactions
Electrophysiological readouts:
Combine molecular manipulations of DNAJC5B with electrophysiological recordings to assess functional consequences on neurotransmitter release
Analyze synchronous vs. asynchronous release components to determine specific aspects affected by DNAJC5B
Differential proteomics:
Compare the stability and post-translational modifications of SNAP-25 in the presence or absence of DNAJC5B
Identify additional clients of DNAJC5B's chaperone activity
Structural biology approaches:
Use cryo-EM or X-ray crystallography to determine the structure of DNAJC5B in complex with SNAP-25
Apply hydrogen-deuterium exchange mass spectrometry to map interaction interfaces
In vivo functional readouts:
Develop genetic models with mutations in the DNAJC5B-SNAP-25 interaction interface
Assess synaptic transmission and plasticity in these models